M H J van Oers
Overview
Explore the profile of M H J van Oers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
669
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Holtzer-Goor K, Bouwmans-Frijters C, Schaafsma M, de Weerdt O, Joosten P, Posthuma E, et al.
Leuk Res
. 2013 Nov;
38(1):84-90.
PMID: 24268350
We performed a comprehensive cost calculation identifying the main cost drivers of treatment of chronic lymphocytic leukaemia in daily practice. In our observational study 160 patient charts were reviewed repeatedly...
12.
Kater A, Wittebol S, Chamuleau M, van Gelder M, van Oers M, Hovon CLL Working Party
Neth J Med
. 2011 Nov;
69(10):422-9.
PMID: 22058261
One of the principal responsibilities of the Chronic Lymphocytic Leukaemia (CLL) Working Party of the Dutch/Belgium Haemato-Oncology Foundation for Adults in the Netherlands (HOVON) is to create up-to-date guidelines for...
13.
Vermeulen M, van Oers M
BMJ Case Rep
. 2011 Jun;
2009.
PMID: 21686704
We describe relapse of chronic inflammatory demyelinating polyneuropathy in a patient who had been in remission for 5 years after treatment with autologous stem cell transplantation. Before the transplant, he...
14.
Jak M, van Bochove G, van Lier R, Eldering E, van Oers M
Leukemia
. 2011 Mar;
25(6):968-78.
PMID: 21403646
In vitro CD40-stimulated chronic lymphocytic leukemia (CLL) cells are resistant to cytotoxic drugs. In sharp contrast, we here show that CD40 stimulation sensitizes CLL cells to rituximab-mediated cell death. This...
15.
Tromp J, Tonino S, Elias J, Jaspers A, Luijks D, Kater A, et al.
Oncogene
. 2010 Jun;
29(36):5071-82.
PMID: 20581863
Chronic lymphocytic leukemia (CLL) cells circulating in peripheral blood (PB) differ from the leukemic fraction in lymph nodes (LNs) with respect to cell division and drug sensitivity. CD40 stimulation of...
16.
17.
Osterborg A, Foa R, Bezares R, Dearden C, Dyer M, Geisler C, et al.
Leukemia
. 2009 Jul;
23(11):1980-8.
PMID: 19626051
The consensus views of an expert roundtable meeting are presented as updated management guidelines for using alemtuzumab in chronic lymphocytic leukemia. Since the publication of previous management guidelines in 2004,...
18.
Mous R, Jaspers A, Luijks D, Mellink C, van Oers M, Kater A, et al.
Leukemia
. 2009 Apr;
23(7):1352-5.
PMID: 19340003
No abstract available.
19.
de Fost M, Out T, de Wilde F, Tjin E, Pals S, van Oers M, et al.
Ann Hematol
. 2008 Feb;
87(6):439-49.
PMID: 18274746
Gaucher disease type I, the most common lysosomal storage disorder, is associated with immunoglobulin abnormalities. We studied the prevalence, risk factors, pathogenesis, and effect of enzyme relation therapy (ERT) on...
20.
Vermeulen M, van Oers M
J Neurol Neurosurg Psychiatry
. 2007 Sep;
78(10):1154.
PMID: 17878198
We describe relapse of chronic inflammatory demyelinating polyneuropathy in a patient who had been in remission for 5 years after treatment with autologous stem cell transplantation. Before the transplant, he...